In this innovative approach, direct delivery of the mimics to tumor cells was attempted through the use of nonliving bacterial minicells (nanoparticles) termed TargomiRs targeting the Endothelial Growth Factor Receptor (EGFR), which is frequently overexpressed in this tumor. The gene discussed is EGFR; the disease is neoplasm.